Our mediation analyses indicated significant indirect effects of maternal folate on GDM risk via each placental hormone individually: GH2 increased risk, whereas hPL reduced risk, findings that are consistent with their established physiological roles in promoting maternal insulin resistance and insulin secretion, respectively [17,18,35]. The gene discussed is LGALS1; the disease is gestational diabetes.